Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioNxt SolutionsXTER:BXT -0.55%31 Market Cap is €25.40 Mil as of Aug. 13, 2026. GuruFocus rates XTER:BXT with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 1,022 Drug Manufacturers companies, BioNxt Solutions ranks worse than 74.85% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioNxt Solutions's share price for the quarter that ended in Mar. 2026 was €0.337. BioNxt Solutions's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 129.54 Mil. Therefore, BioNxt Solutions's market cap for the quarter that ended in Mar. 2026 was €43.66 Mil.
BioNxt Solutions's quarterly market cap
declined
from Sep. 2025 (€65.43 Mil) to Dec. 2025 (€54.51 Mil) and
declined
from Dec. 2025 (€54.51 Mil) to Mar. 2026 (€43.66 Mil).
BioNxt Solutions's annual market cap
declined
from Dec. 2023 (€40.04 Mil) to Dec. 2024 (€30.73 Mil) but then
increased
from Dec. 2024 (€30.73 Mil) to Dec. 2025 (€54.51 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioNxt Solutions's Enterprise Value for Today is €29.32 Mil.
BioNxt Solutions (XTER:BXT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BioNxt Solutions Market Cap Related Terms
BioNxt Solutions Market Cap Historical Data
* Premium members only.
The historical data trend for BioNxt Solutions's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioNxt Solutions Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where BioNxt Solutions's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BioNxt Solutions's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNxt Solutions (XTER:BXT) has a Market Cap of €25.40 Mil as of Aug. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioNxt Solutions and its competitors. According to the industry distribution chart, BioNxt Solutions ranks #765 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 74.9%.
Is BioNxt Solutions' Market Cap too high?
BioNxt Solutions' current Market Cap is €25.40 Mil. Based on the distribution chart, BioNxt Solutions ranks #765 out of 1022 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BioNxt Solutions has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does BioNxt Solutions' Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BioNxt Solutions ranks #765 out of 1022 companies for Market Cap. This places BioNxt Solutions in the lower half of its industry. The industry median Market Cap is 231.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 231.08, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioNxt Solutions and its competitors. For the Drug Manufacturers industry, the median Market Cap is 231.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioNxt Solutions's current Market Cap is €25.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNxt Solutions stock overvalued right now?
BioNxt Solutions (XTER:BXT) has a current Market Cap of €25.40 Mil. The current Market Cap is €25.40 Mil. BioNxt Solutions' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BioNxt Solutions (XTER:BXT), the current Market Cap is €25.40 Mil as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioNxt Solutions Inc is is a bioscience innovator focused on next-generation drug delivery systems. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, focused on European markets. The company is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes. Its pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, BNT24004. Its geographic areas are Austria, Germany, Switzerland regions.
31GF Score
Get the complete analysis for XTER:BXT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:BXT has been successfully added to your 
